Filing Details
- Accession Number:
- 0001846253-25-000013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-19 20:51:18
- Reporting Period:
- 2025-02-15
- Filing Date:
- 2025-02-19
- Accepted Time:
- 2025-02-19 20:51:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1846253 | Omniab Inc. | OABI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1237556 | W Matthew Foehr | 5980 Horton Street, Ste 600 Emeryville CA 94608 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-15 | 26,549 | $0.00 | 3,776,188 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-02-16 | 36,458 | $0.00 | 3,812,646 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-18 | 13,964 | $3.68 | 3,798,682 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-19 | 19,522 | $3.67 | 3,779,160 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2025-02-15 | 26,549 | $0.00 | 26,549 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2025-02-16 | 36,458 | $0.00 | 36,458 | $0.00 |
| Common Stock | Restricted Stock Units | Acquisiton | 2025-02-18 | 175,000 | $0.00 | 175,000 | $0.00 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2025-02-18 | 1,050,000 | $0.00 | 1,050,000 | $3.66 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 208,846 | No | 4 | M | Direct | ||
| 172,388 | No | 4 | M | Direct | ||
| 347,388 | No | 4 | A | Direct | ||
| 1,050,000 | 2035-02-18 | No | 4 | A | Direct |
Footnotes
- Represents the vesting of an RSU grant which occurs in three substantially equal annual installments beginning on February 15, 2023.
- Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- Represents the vesting of an RSU grant which occurs in three substantially equal annual installments beginning on February 16, 2025.
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and do not represent discretionary trades by the reporting person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.83. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.71. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
- The RSU grant vests in three substantially equal annual installments beginning on February 18, 2026.
- The Stock Option grant vests and is exercisable as to 12.5% of the underlying shares 6 months after the grant date, and in 42 substantially equal monthly installments thereafter.
Billionaire Hedge Funds
